{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:23:10Z","timestamp":1772756590604,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800338"],"award-info":[{"award-number":["81800338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.lfs.2020.118496","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T14:01:38Z","timestamp":1601042498000},"page":"118496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019"],"prefix":"10.1016","volume":"262","author":[{"given":"Wenyi","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dachun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118496_bb0005","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"V. Coronaviridae Study Group of the International Committee on Taxonomy of","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.lfs.2020.118496_bb0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.lfs.2020.118496_bb0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118496_bb0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0025","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/nsr\/nwaa036","article-title":"On the origin and continuing evolution of SARS-CoV-2","volume":"7","author":"Tang","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.lfs.2020.118496_bb0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118496_bb0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lfs.2020.118496_bb0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.lfs.2020.118496_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","article-title":"Cardiovascular complications of severe acute respiratory syndrome","volume":"82","author":"Yu","year":"2006","journal-title":"Postgrad. Med. J."},{"issue":"2003","key":"10.1016\/j.lfs.2020.118496_bb0050","first-page":"361","article-title":"The clinical characteristics of SARS and its treatment and prognosis with attached clinical reports of 220 cases","volume":"24","author":"T.g.o.S.o.X.h.C","year":"2003","journal-title":"Journal of Capital University of Medical Sciences"},{"key":"10.1016\/j.lfs.2020.118496_bb0055","first-page":"1708","article-title":"Clinical characteristics of 2019 novel coronavirus infection in China","volume":"382","author":"Guan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0060","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/166.5.978","article-title":"An experimental model for dilated cardiomyopathy after rabbit coronavirus infection","volume":"166","author":"Alexander","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118496_bb0065","first-page":"ehaa248","article-title":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin","volume":"31","author":"Hu","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2020.118496_bb0070","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/S0140-6736(20)31307-6","article-title":"Myocarditis in a 16-year-old boy positive for SARS-CoV-2","volume":"395","author":"Gnecchi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118496_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"Corrales-Medina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2020.118496_bb0080","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered lipid metabolism in recovered SARS patients twelve years after infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.118496_bb0085","article-title":"Cardiac involvement in recovered COVID-19 patients identified by magnetic resonance imaging","author":"Huang","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.lfs.2020.118496_bb0090","first-page":"E1","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.lfs.2020.118496_bb0095","first-page":"113","volume":"22","year":"2020","journal-title":"China CDC Weekly"},{"key":"10.1016\/j.lfs.2020.118496_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0105","author":"S. G, Shanghai Health commission"},{"key":"10.1016\/j.lfs.2020.118496_bb0110","first-page":"813","article-title":"Damage to non-pulmonary organs like heart and kidney in SARS patients:an analysis of 330 cases","volume":"24","author":"Rong","year":"2003","journal-title":"Acadmeic Journal of Second military medicine university"},{"key":"10.1016\/j.lfs.2020.118496_bb0115","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.lfs.2020.118496_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.118496_bb0125","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of Cardiac Infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.lfs.2020.118496_bb0130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118496_bb0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2020.118496_bb0140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.lfs.2020.118496_bb0145","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.118496_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2012.08.018","article-title":"Angiotensin converting enzyme 2 and atherosclerosis","volume":"226","author":"Wang","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2020.118496_bb0155","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118496_bb0160","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.lfs.2020.118496_bb0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","article-title":"New fronts emerge in the influenza cytokine storm","volume":"39","author":"Guo","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.lfs.2020.118496_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2020.118496_bb0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0180","article-title":"Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19)","author":"Wu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0185","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2174\/157016112801784549","article-title":"Crosstalk between inflammation and coagulation: the lessons of sepsis","volume":"10","author":"van der Poll","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118496_bb0190","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lfs.2020.118496_bb0195","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0200","first-page":"727","article-title":"Clinical features and mechanisms of heart injury in patients suffered from severe acute respiratory syndrome","volume":"31","author":"Duan","year":"2003","journal-title":"Chinese J Cardiol"},{"key":"10.1016\/j.lfs.2020.118496_bb0205","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/cid\/ciw395","article-title":"Switching lopinavir\/ritonavir to atazanavir\/ritonavir vs adding atorvastatin in HIV-infected patients receiving second-line antiretroviral therapy with hypercholesterolemia: a randomized controlled trial","volume":"63","author":"Wangpatharawanit","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118496_bb0210","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.1980.01640290097026","article-title":"Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine","volume":"116","author":"Tanenbaum","year":"1980","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.lfs.2020.118496_bb0215","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41591-020-0888-2","article-title":"The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin","volume":"22","author":"Chorin","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0220","author":"Z"},{"key":"10.1016\/j.lfs.2020.118496_bb0225","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1536\/ihj.37.905","article-title":"Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C","volume":"37","author":"Teragawa","year":"1996","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.lfs.2020.118496_bb0230","unstructured":"The Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Provisional 7th Edition) http:\/\/wwwnhcgovcn\/yzygj\/s7652m\/202003\/a31191442e29474b98bfed5579d5af95shtml, 2020."},{"key":"10.1016\/j.lfs.2020.118496_bb0235","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0240","unstructured":"F.-N. Hung, K.-C. Lung, R. Liu, W Chung, M. Chu, J. Chan, et al, Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, Lancet, 395 (2020) 1695\u20131704."},{"key":"10.1016\/j.lfs.2020.118496_bb0245","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.lfs.2020.118496_bb0250","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0255","first-page":"1444","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0260","first-page":"215","article-title":"Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0265","first-page":"221","article-title":"Structural basis for the recognition of the 2019-nCoV by human ACE2","volume":"581","author":"Yan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2020.118496_bb0275","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Bioscience trends"},{"key":"10.1016\/j.lfs.2020.118496_bb0280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118496_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118496_bb0295","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/CCM.0b013e3181958d91","article-title":"Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models","volume":"37","author":"Hagiwara","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118496_bb0300","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10787-018-0535-4","article-title":"Immunomodulatory properties of captopril, an ACE inhibitor, on LPS-induced lung inflammation and fibrosis as well as oxidative stress","volume":"27","author":"Boskabadi","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.lfs.2020.118496_bb0305","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1183\/09031936.00162006","article-title":"Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia","volume":"31","author":"Mortensen","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118496_bb0310","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118496_bb0315","author":"https:\/\/wwweshonlineorg\/spotlights\/esh-statement-on-covid-19\/"},{"key":"10.1016\/j.lfs.2020.118496_bb0320","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2020.118496_bb0325","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Critical care (London, England)"},{"key":"10.1016\/j.lfs.2020.118496_bb0330","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118496_bb0335","series-title":"Cytokine Storm Is the Therapeutic Target of Severe SARS-CoV-2 Infection","year":"2020"},{"key":"10.1016\/j.lfs.2020.118496_bb0340","doi-asserted-by":"crossref","first-page":"318","DOI":"10.32794\/mr11250065","article-title":"Melatonin, cardiovascular disease and COVID-19: a potential therapeutic strategy?","volume":"3","author":"Dominguez-Rodriguez","year":"2020","journal-title":"Melatonin Research"},{"key":"10.1016\/j.lfs.2020.118496_bb0345","article-title":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","author":"Wan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0350","article-title":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","author":"Zhou","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0355","author":"Zhou"},{"key":"10.1016\/j.lfs.2020.118496_bb0360","article-title":"Potent human neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Ju","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.lfs.2020.118496_bb0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118496_bb0370","first-page":"E001","volume":"48","year":"2020","journal-title":"China J Cardiol"},{"key":"10.1016\/j.lfs.2020.118496_bb0375","doi-asserted-by":"crossref","first-page":"e810","DOI":"10.1161\/CIRCULATIONAHA.120.047011","article-title":"CSC expert consensus on principles of clinical management of patients with severe emergent cardiovascular diseases during the COVID-19 epidemic","volume":"141","author":"Han","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118496_bb0380","series-title":"ACC Clinical Bulletin: Cardiac Implications of Novel Wuhan Coronavirus (COVID-19 )","author":"Madjid","year":"2020"},{"key":"10.1016\/j.lfs.2020.118496_bb0385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.abb3221","article-title":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)","volume":"368","author":"Li","year":"2020","journal-title":"Science (New York, N.Y.)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520312492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520312492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:35:49Z","timestamp":1758400549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520312492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":76,"alternative-id":["S0024320520312492"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118496","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118496"}}